
Trevi Therapeutics, Inc. is a biotechnology company in the healthcare sector on NASDAQ, led by Jennifer Good, with a market cap of $1.6B. As of Q3 2025, 106% of shares are held by 164 institutional investors, with NEA Management Company, LLC as the largest holder at 10.86%.
Overview of institutional ownership in TRVI as of Q3 2025 with a market cap of $1.1B
Based on market cap of $1.1B as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.
Institutions with the largest positions in TRVI as of Q3 2025
| Institution | Position Value |
|---|---|
NEA Management Company, LLC Venture Capital | $121.0M 6.64% of portfolio |
Frazier Life Sciences Management, L.P. Venture Capital | $93.9M 2.81% of portfolio |
B BlackRock, Inc. Institution | $90.6M 0.00% of portfolio |
R Rubric Capital Management LP Hedge Fund•Long/Short | $78.1M 1.12% of portfolio |
VANGUARD GROUP INC Institution | $53.3M 0.00% of portfolio |
VIKING GLOBAL INVESTORS LP Hedge Fund•Long/Short | $46.9M 0.12% of portfolio |
Vivo Capital, LLC Venture Capital | $46.6M 3.75% of portfolio |
Marshall Wace LLP Institution | $44.3M 0.05% of portfolio |
MORGAN STANLEY RIA/Wealth | $39.4M 0.00% of portfolio |
ALLIANCEBERNSTEIN L.P. Long Only Manager | $39.3M 0.01% of portfolio |
Institutional buying and selling activity for TRVI in Q3 2025
| Institution | Net Bought |
|---|---|
VIKING GLOBAL INVESTORS LP Hedge Fund•Long/Short | +$32.8M +3.6M shares |
MORGAN STANLEY RIA/Wealth | +$30.0M +3.3M shares |
WELLINGTON MANAGEMENT CO LLP Long Only Manager | +$28.2M +3.1M shares |
FMR LLC Institution | +$26.8M +2.9M shares |
Marshall Wace LLP Institution | +$21.6M +2.4M shares |
B BlackRock, Inc. Institution | +$15.5M +1.7M shares |
SUSQUEHANNA INTERNATIONAL GROUP, LLP Private Equity | +$13.5M +1.5M shares |
Logos Global Management LP Hedge Fund•Long/Short | +$12.4M +1.4M shares |
P PUTNAM FL INVESTMENT MANAGEMENT CO Institution | +$8.8M +961.2K shares |
BANK OF AMERICA CORP /DE/ Institution | +$6.8M +739.3K shares |
| Institution | Net Sold |
|---|---|
BALYASNY ASSET MANAGEMENT LLC Hedge Fund•Multi-Strategy | −$15.8M −1.7M shares |
S Siren, L.L.C. Institution | −$12.8M −1.4M shares |
Octagon Capital Advisors LP Hedge Fund•Sector | −$7.8M −857.0K shares |
Point72 Asset Management, L.P. Hedge Fund•Multi-Strategy | −$7.2M −786.7K shares |
MAI Wealth Advisors RIA/Wealth | −$6.9M −749.1K shares |
R ROYAL BANK OF CANADA Institution | −$6.0M −655.2K shares |
A Alyeska Investment Group, L.P. Hedge Fund•Multi-Strategy | −$3.6M −650.0K shares |
BARCLAYS PLC Institution | −$2.7M −298.6K shares |
L Longwood Capital Partners LLC Institution | −$2.7M −493.7K shares |
T Tejara Capital Ltd Institution | −$2.6M −289.2K shares |
Institutions that initiated new positions or completely exited TRVI in Q3 2025
| Institution | Position Value |
|---|---|
P PEREGRINE CAPITAL MANAGEMENT LLC Long Only Manager | $5.7M 620.5K shares |
StemPoint Capital LP Hedge Fund•Long/Short | $3.2M 350.7K shares |
V Velan Capital Investment Management LP Institution | $1.9M 205.0K shares |
S Swiss National Bank Institution | $1.5M 161.7K shares |
UBS GLOBAL ASSET MANAGEMENT AMERICAS INC Long Only Manager | $1.1M 116.5K shares |
NAN FUNG TRINITY Ltd RIA/Wealth | $819.6K 89.6K shares |
S SEI INVESTMENTS CO Institution | $785.1K 85.8K shares |
CAPSTONE INVESTMENT ADVISORS, LLC Hedge Fund•Multi-Strategy | $670.6K 73.3K shares |
Optimize Financial Inc RIA/Wealth | $554.5K 60.6K shares |
DLD Asset Management, LP Hedge Fund•Multi-Strategy | $503.3K 55.0K shares |
| Institution | Previous Position |
|---|---|
A Alyeska Investment Group, L.P. Hedge Fund•Multi-Strategy | $3.6M 650.0K shares |
L Longwood Capital Partners LLC Institution | $2.7M 493.7K shares |
AMERIPRISE FINANCIAL INC Institution | $847.1K 154.9K shares |
Y Y-Intercept Ltd Institution | $475.0K 86.8K shares |
Polar Securities Inc. Hedge Fund•Multi-Strategy | $406.4K 74.3K shares |
X XTX Topco Ltd Institution | $353.3K 64.6K shares |
LEUCADIA NATIONAL CORP Institution | $300.6K 55.0K shares |
B BRIDGEWAY CAPITAL MANAGEMENT INC Long Only Manager | $246.0K 45.0K shares |
O OMERS ADMINISTRATION Corp Institution | $191.5K 35.0K shares |
Trexquant Investment LP Hedge Fund•Quant | $185.8K 34.0K shares |
Institutions with the largest Call and Put options positions in TRVI as of Q3 2025
| Institution | Position Value |
|---|---|
SUSQUEHANNA INTERNATIONAL GROUP, LLP Private Equity | $3.8M 4.1K contracts |
S SPHERA FUNDS MANAGEMENT LTD. Institution | $1.2M 1.3K contracts |
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | $409.9K 448.0 contracts |
Caption Management, LLC Hedge Fund•Long/Short | $219.6K 240.0 contracts |
J JANE STREET GROUP, LLC Institution | $166.5K 182.0 contracts |
PFS Partners, LLC RIA/Wealth | - - contracts |
| Institution | Position Value |
|---|---|
SUSQUEHANNA INTERNATIONAL GROUP, LLP Private Equity | $6.6M 7.2K contracts |
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | $2.1M 2.3K contracts |
J JANE STREET GROUP, LLC Institution | $1.9M 2.0K contracts |
Caption Management, LLC Hedge Fund•Long/Short | $640.5K 700.0 contracts |
L LMR Partners LLP Institution | - - contracts |
Institutions with TRVI as the highest % of their portfolio as of Q3 2025
| Institution | Portfolio Weight |
|---|---|
A ACORN CAPITAL ADVISORS, LLC Venture Capital | 9.96% $19.6M |
6.65% $11.5M | |
NEA Management Company, LLC Venture Capital | 6.64% $121.0M |
MPM Oncology Impact Management LP Institution | 5.10% $31.2M |
Octagon Capital Advisors LP Hedge Fund•Sector | 4.04% $25.8M |
Vivo Capital, LLC Venture Capital | 3.75% $46.6M |
A Artia Global Partners LP Hedge Fund•Long/Short | 3.22% $18.3M |
Frazier Life Sciences Management, L.P. Venture Capital | 2.81% $93.9M |
Affinity Asset Advisors, LLC Hedge Fund•Long/Short | 2.61% $25.6M |
Logos Global Management LP Hedge Fund•Long/Short | 2.04% $20.1M |
Discover hedge funds investing in TRVI


| Top Holding | Sector | Market Value | Weight |
|---|---|---|---|
Semiconductors Technology | $4.1B | 2.62% | |
Software - Infrastructure Technology | $3.2B | 2.05% | |
Consumer Electronics Technology | $2.8B | 1.76% |
We use cookies for analytics. See our Privacy and Cookie Policy.